WT, n = 10 mice
Hanioka, N., Jinno, H., Nishimura, T., and Ando, M
Key Takeaways Administration (in-office injection) is viable in all 50 states under medical board oversight Dispensing (at-home supply) is prohibited or severely restricted in major markets The FDA shortage resolution ended enforcement discretion for compounded GLP-1s State pharmacy dispensing permits are non-negotiable if you dispense medications Mid-level practitioner authority for dispensing varies significantly by state Medical director oversight is the legal foundation for any GLP-1 program 503B office use stock cannot be redistributed for at-home patient use Non-compliance creates practice-ending legal exposure
Researchers examine it for its relationship to amylin receptor signaling, appetite-related biological pathways, glucose-adjacent metabolic regulation, and energy-balance systems
But they serve entirely different purposes
Conclusion We demonstrated that a 3-month milk intervention of the recommended 3 cups/day among healthy older adults with habitual low milk intake effectively increased brain GSH concentrations
